NASDAQ

OncoMed Pharmaceuticals Announces Pricing of Public Offering of Common Stock

REDWOOD CITY, Calif., Aug. 18, 2016 (GLOBE NEWSWIRE) -- OncoMed Pharmaceuticals, Inc. (Nasdaq:OMED), a ...

Director Declaration

18 August 2016 13:00 New external board appointment Listing Rule LR 9.6.14 R (2) ...

BeiGene Receives Approval to Initiate Clinical Trials in China with PARP Inhibitor BGB-290

WALTHAM, Mass., Aug. 18, 2016 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ:BGNE), a clinical-stage biopharmaceutical ...

Poseida Therapeutics Expands Executive Leadership Team

SAN DIEGO, Aug. 18, 2016 (GLOBE NEWSWIRE) -- Poseida Therapeutics, Inc. (“Poseida”), a San ...

OncoMed Pharmaceuticals Announces Proposed Public Offering of Common Stock

REDWOOD CITY, Calif., Aug. 17, 2016 (GLOBE NEWSWIRE) -- OncoMed Pharmaceuticals, Inc. (Nasdaq:OMED), a ...

SinfoníaRx Now Requires Credentialing for MTM Pharmacists

TUCSON Ariz., Aug. 17, 2016 (GLOBE NEWSWIRE) -- SinfoníaRx announced today that they will ...